Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pharmacoeconomics|June 18, 2013
Incorporating process utility into quality adjusted life years: a systematic review of empirical studiesVictoria K Brennan, Simon DixonApplied Health Economics and Health Policy|March 30, 2021
Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory StudyVictoria K Brennan, Georgina Jones, Stephen Radley, et al.Expert Review of Anticancer Therapy|November 2, 2020
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trialsRichard F Pollock, Victoria K Brennan, Suki Shergill, et al.The Cochrane Database of Systematic Reviews|May 13, 2011
Timing of breast surgery in premenopausal breast cancer patientsMiny Samuel, Khin Lay Wai, Victoria K Brennan, et al.Expert Review of Anticancer Therapy|September 15, 2020
Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysisRichard F Pollock, Victoria K Brennan, Ralph Peters, et al.Clinicoeconomics and Outcomes Research : CEOR|September 30, 2021
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with RadioembolizationRichard F Pollock, Fabien Colaone, Suki Shergill, et al.Journal of Medical Economics|February 19, 2020
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UKRichard F Pollock, Fabien Colaone, Laura Guardiola, et al.Respiratory Medicine|January 28, 2005
True device compliance: the need to consider both competence and contrivanceVictoria K Brennan, Liesl M Osman, Hamilton Graham, et al.Advances in Therapy|March 13, 2022
Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of LifeIon Agirrezabal, Victoria K Brennan, Fabien Colaone, et al.Journal of Medical Economics|April 30, 2014
Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modelingVictoria K Brennan, Ann D Colosia, Catherine Copley-Merriman, et al.Pageof 2